<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[aurivapharma.com]]></title><description><![CDATA[Peptides Made Easy, Results Delivered]]></description><link>https://www.aurivapharma.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Sat, 13 Jun 2026 09:19:50 GMT</lastBuildDate><atom:link href="https://www.aurivapharma.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Peptide Storage &#38; Handling: Good-Practice Basics]]></title><description><![CDATA[General good-practice guidance on storing and handling lyophilised research peptides — temperature, light, reconstitution and records.]]></description><link>https://www.aurivapharma.com/post/peptide-storage-handling-good-practice-basics</link><guid isPermaLink="false">6a24b6e4723e0825bac8045d</guid><pubDate>Sun, 07 Jun 2026 00:10:12 GMT</pubDate><dc:creator>aurivapharma</dc:creator></item><item><title><![CDATA[Retatrutide vs Tirzepatide: Key Differences]]></title><description><![CDATA[A side-by-side research comparison of retatrutide and tirzepatide — receptor targets and why both are studied.]]></description><link>https://www.aurivapharma.com/post/retatrutide-vs-tirzepatide-key-differences</link><guid isPermaLink="false">6a24b6e37af0f73356941926</guid><pubDate>Sun, 07 Jun 2026 00:10:11 GMT</pubDate><dc:creator>aurivapharma</dc:creator></item><item><title><![CDATA[Tirzepatide: A Research Overview]]></title><description><![CDATA[A research overview of tirzepatide — the dual agonist acting on GLP-1 and GIP receptors, its formats and storage.]]></description><link>https://www.aurivapharma.com/post/tirzepatide-a-research-overview</link><guid isPermaLink="false">6a24b6e21f44c606b37a5652</guid><pubDate>Sun, 07 Jun 2026 00:10:11 GMT</pubDate><dc:creator>aurivapharma</dc:creator></item><item><title><![CDATA[Retatrutide: A Research Overview]]></title><description><![CDATA[A research overview of retatrutide — the triple agonist acting on GLP-1, GIP and glucagon receptors, its formats and storage.]]></description><link>https://www.aurivapharma.com/post/retatrutide-a-research-overview</link><guid isPermaLink="false">6a24b6ae1f44c606b37a5608</guid><pubDate>Sun, 07 Jun 2026 00:09:21 GMT</pubDate><dc:creator>aurivapharma</dc:creator></item><item><title><![CDATA[What Are Research Peptides? A Beginner’s Guide]]></title><description><![CDATA[What research peptides are, how they are presented and stored, and what "research use only" means.]]></description><link>https://www.aurivapharma.com/post/what-are-research-peptides-a-beginner-s-guide</link><guid isPermaLink="false">6a24b5f07af0f733569417db</guid><pubDate>Sun, 07 Jun 2026 00:06:08 GMT</pubDate><dc:creator>aurivapharma</dc:creator></item></channel></rss>